XOMA Corporation Annual report pursuant to Section 13 and 15(d)

Licensing and Other Arrangements - Sale of Future Revenue Streams (Details) $ in Thousands		12 Months Ended
	Dec. 21, 2016 USD ($) agreement period	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Licensing and other arrangements
Unearned revenue recognized under units-of-revenue method		$ (1,877)	$ (1,642)
Revenue recognized under units-of-revenue method		1,877	1,642
Unearned revenue recognized under units-of-revenue method, current		1,899	1,641
Unearned revenue recognized under units-of-revenue method, noncurrent		9,550	11,685
HealthCare Royalty Partners II, L.P \| Royalty Sale Agreements
Licensing and other arrangements
Number of agreements \| agreement	2
Unearned revenue recognized under units-of-revenue method	$ 18,000
Revenue recognized under units-of-revenue method		1,900	1,600
Unearned revenue recognized under units-of-revenue method, current		1,900	1,600
Unearned revenue recognized under units-of-revenue method, noncurrent		$ 9,600	$ 11,700
HealthCare Royalty Partners II, L.P \| First Royalty Sale Agreement
Licensing and other arrangements
Cash payment received	6,500
Eligible potential additional payments receivable upon achievement of specified net sales milestones in future years	$ 4,000
Number of milestone periods \| period	3
HealthCare Royalty Partners II, L.P \| Second Royalty Sale Agreement
Licensing and other arrangements
Cash payment received	$ 11,500